CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Content managed by and international Editorial Board, chaired by Professor Desmond Julian
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals
Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Cardiovascular News



Page summary
Text size
News quick search
Cardiovascular news provides daily news updates to help you stay informed.
 

Atherogenic dyslipidemia commonly found with stable coronary disease


1 September 2010

MedWire News: A significant proportion of patients with coronary artery disease (CAD) could benefit from efforts to increase their high-density lipoprotein (HDL) cholesterol levels and reduce triglycerides, researchers say.

Their cross-sectional study indicated that more than half of all patients with stable coronary disease may have low HDL cholesterol or raised triglycerides, regardless of whether or not they are taking statins, with one in eight having both conditions simultaneously.

Atherogenic dyslipidemia is characterized by high triglycerides and low HDL cholesterol, frequently associated with elevated apolipoprotein B and small, dense low-density lipoprotein (LDL) particles, explain C Lahoz (Hospital Carlos III, Madrid, Spain) and co-workers.

They investigated its prevalence in 7823 Spanish individuals admitted to hospital for a coronary event or coronary revascularization between 6 months and 10 years previously.

Atherogenic dyslipidemia was considered to be the simultaneous presence of low HDL cholesterol, of less than 1.03 mmol/l (40 mg/dl) in men or 1.29 mmol/l (50 mg/dl) in women, and elevated triglycerides of at least 1.7 mmol/l (150 mg/dl).

The mean age of participants was 65.3 years, 73.6% were men, and 80.3% were receiving treatment with statins.

Low HDL cholesterol was observed in 26.3% of the patients studied, and elevated triglycerides in 39.7%, with 13.0% defined as having atherogenic dyslipidemia.

The occurrence of atherogenic dyslipidemia was particularly high among individuals meeting the criteria for the metabolic syndrome, at 30.9%.

Factors independently associated with atherogenic dyslipidemia included female gender, having had a non-ST elevation acute coronary syndrome or coronary revascularization, atrial fibrillation, and higher body mass index, LDL cholesterol, systolic blood pressure and blood glucose levels.

In contrast, age and glomerular filtration rate were significantly and inversely associated with atherogenic dyslipidemia, the authors note in the journal Nutrition, Metabolism, and Cardiovascular Diseases.

They conclude: “A large percentage of patients with coronary disease have less than ideal concentrations of HDL-cholesterol and triglycerides, which have been associated with an increased risk of new events.

“Intervention aimed at these factors may prove to be a useful tool in the reduction of the residual vascular risk in this population.”

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010

Nutr Met Cardiovasc Dis 2010; Advance online publication



© Copyright Springer Healthcare Ltd, 2012

Related Content

Congress Reports
AHA 2011

EASD 2011

Your opinion matters – help to shape the future of InCirculation.net by completing our short survey. Click here!

To receive our weekly newsletter, register or update your profile. Click here!
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions